3X4 Genetics

3x4genetics.io

3x4 Genetics is a genetics-based foundational health network that combines: advanced genetics testing, nutritional genomics education and a global network of accredited practitioners to help people listen to their bodies and make sound, daily choices to live longer, healthier and better lives.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research

MEDOLIFE RX ANNOUNCES CHANGES TO MANAGEMENT AND IMPROVEMENTS TO AELIA’S MARKETING EFFORTS

Medolife Rx, Inc. | February 07, 2022

news image

Medolife Rx, Inc. a global integrated biopharmaceutical company with manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. that the Company is in progress of revamping their online marketing platform, starting off with a change in the marketing and brand development for their AELIA brand wellness products that utilize the company’s polarized ingredients. Medolife believes these changes will bring greater product awareness and improved online...

Read More

INOVIO REPORTS FDA PARTIAL CLINICAL HOLD FOR PLANNED PHASE 2 / 3 TRIAL OF COVID-19 VACCINE CANDIDATE INO-4800

INOVIO | September 28, 2020

news image

INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that the U.S. Food and Drug Administration (FDA) has notified the company it has additional questions about the company's planned Phase 2/3 trial of its COVID-19 vaccine candidate INO-4800, including its CELLECTRA® 2000 delivery device to be used in the trial. Until the FDA's questions have been satisfac...

Read More

Cell and Gene Therapy

PHYTOLON AND GINKGO BIOWORKS COLLABORATE TO TAKE BIOLOGICAL PRODUCTION OF VIBRANT FOOD COLORS TO THE NEXT LEVEL

Phytolon; Ginkgo Bioworks | February 28, 2022

news image

Phytolon, a growing startup company making natural food colorants, announced a partnership today with Ginkgo Bioworks the leading horizontal platform for cell programming, to produce vibrant cultured food colors via fermentation of yeast. Under this partnership, Phytolon is leveraging Ginkgo's ability to engineer biology at scale to work together on the production of vibrant betalain pigments, the healthy and colorful compounds found in foods like beets and cactus fruit. The project aims to ...

Read More

Industrial Impact

ANTHOS THERAPEUTICS ANNOUNCES THAT ABELACIMAB HAS RECEIVED FDA FAST TRACK DESIGNATION FOR THE TREATMENT OF THROMBOSIS ASSOCIATED WITH CANCER

Anthos Therapeutics | July 11, 2022

news image

Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, announced that the U.S. Food and Drug Administration has granted Fast Track Designation to its investigational Factor XI inhibitor, abelacimab, for the treatment of thrombosis associated with cancer. The company will also be announcing this important milestone today at a session of the ongoing 2022 Congress of the International Society on Thrombosis and Haemostas...

Read More
news image

Research

MEDOLIFE RX ANNOUNCES CHANGES TO MANAGEMENT AND IMPROVEMENTS TO AELIA’S MARKETING EFFORTS

Medolife Rx, Inc. | February 07, 2022

Medolife Rx, Inc. a global integrated biopharmaceutical company with manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. that the Company is in progress of revamping their online marketing platform, starting off with a change in the marketing and brand development for their AELIA brand wellness products that utilize the company’s polarized ingredients. Medolife believes these changes will bring greater product awareness and improved online...

Read More
news image

INOVIO REPORTS FDA PARTIAL CLINICAL HOLD FOR PLANNED PHASE 2 / 3 TRIAL OF COVID-19 VACCINE CANDIDATE INO-4800

INOVIO | September 28, 2020

INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that the U.S. Food and Drug Administration (FDA) has notified the company it has additional questions about the company's planned Phase 2/3 trial of its COVID-19 vaccine candidate INO-4800, including its CELLECTRA® 2000 delivery device to be used in the trial. Until the FDA's questions have been satisfac...

Read More
news image

Cell and Gene Therapy

PHYTOLON AND GINKGO BIOWORKS COLLABORATE TO TAKE BIOLOGICAL PRODUCTION OF VIBRANT FOOD COLORS TO THE NEXT LEVEL

Phytolon; Ginkgo Bioworks | February 28, 2022

Phytolon, a growing startup company making natural food colorants, announced a partnership today with Ginkgo Bioworks the leading horizontal platform for cell programming, to produce vibrant cultured food colors via fermentation of yeast. Under this partnership, Phytolon is leveraging Ginkgo's ability to engineer biology at scale to work together on the production of vibrant betalain pigments, the healthy and colorful compounds found in foods like beets and cactus fruit. The project aims to ...

Read More
news image

Industrial Impact

ANTHOS THERAPEUTICS ANNOUNCES THAT ABELACIMAB HAS RECEIVED FDA FAST TRACK DESIGNATION FOR THE TREATMENT OF THROMBOSIS ASSOCIATED WITH CANCER

Anthos Therapeutics | July 11, 2022

Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, announced that the U.S. Food and Drug Administration has granted Fast Track Designation to its investigational Factor XI inhibitor, abelacimab, for the treatment of thrombosis associated with cancer. The company will also be announcing this important milestone today at a session of the ongoing 2022 Congress of the International Society on Thrombosis and Haemostas...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us